Jalosome Oral Barrier UK, IT, PT, TR, RO, ES, SE, DK, NO, FI, SK, CZ, HU

Organization name

Labomar S.p.A.

SRN

IT-MF-000007965

Manufacturer status

Active

Certificate health across this manufacturer's portfolio.

1 warning recorded — scroll inside the panel to see all entries.

• CW999

  Do not use if hypersensitive or allergic to any component. Suspend treatment in the presence of abnormal reactions Once opened the stickpack, use all the content Do not use the product after the expiry date printed on the package. Keep out of the reach of children. Do not use if the package is not intact. Expiry date refers to the product in its intact package, properly stored.

Primary placement in Italy; available across 12 countries total.

Trade name

Jalosome Oral Barrier UK, IT, PT, TR, RO, ES, SE, DK, NO, FI, SK, CZ, HU

UDI-DI code

D-FTP082EZ

Basic UDI-DI

B-FTP082EZ

Reference / catalog number

FTP082

Issuing entity

EUDAMED

Risk category

Class IIa

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

Jalosome Oral Barrier is a medical device indicated for the management of the painful symptoms of the mucositis of the oropharyngeal cavity.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

European Medical Device Nomenclature — the EU product classification assigned to this device.

• V9099VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER